Predictions of Bedaquiline and Pretomanid Target Attainment in Lung Lesions of Tuberculosis Patients using Translational Minimal Physiologically Based Pharmacokinetic Modeling-Reference-Cited by-同舟云学术

Predictions of Bedaquiline and Pretomanid Target Attainment in Lung Lesions of Tuberculosis Patients using Translational Minimal Physiologically Based Pharmacokinetic Modeling

Published:2023-02-19 Issue:3 Volume:62 Page:519-532
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Mehta Krina^ORCID,Guo Tingjie,van der Graaf Piet H.,van Hasselt J. G. Coen

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40262-023-01217-7.pdf

Reference42 articles.

1. World Health Organization. Consolidated operational guidelines on handbook tuberculosis. Geneva: World Health Organization; 2020. p. 132.

2. Khoshnood S, Goudarzi M, Taki E, Darbandi A, Kouhsari E, Heidary M, et al. Bedaquiline: current status and future perspectives. J Glob Antimicrob Resist. 2021;25:48–59. https://doi.org/10.1016/j.jgar.2021.02.017.

3. Stancil SL, Mirzayev F, Abdel-Rahman SM. Profiling pretomanid as a therapeutic option for tb infection: evidence to date. Drug Des Devel Ther. 2021;15:2815–30.

4. Conradie F, Diacon AH, Ngubane N, Howell P, Everitt D, Crook AM, et al. Treatment of highly drug-resistant pulmonary tuberculosis. N Engl J Med. 2020;382(10):893–902.

5. Sarathy JP, Dartois V. Caseum: a Niche for Mycobacterium tuberculosis drug-tolerant persisters. Clin Microbiol Rev. 2020;33(3):e00159-19.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic PET reveals compartmentalized brain and lung tissue antibiotic exposures of tuberculosis drugs;Nature Communications;2024-08-14

2. stormTB: A web-based simulator of a murine minimal-PBPK model for anti-tuberculosis treatments;2024-07-08

3. Relative Contributions of the Novel Diarylquinoline TBAJ-876 and its Active Metabolite to the Bactericidal Activity in a Murine Model of Tuberculosis;The Journal of Infectious Diseases;2024-06-28

4. Predictions of Bedaquiline Central Nervous System Exposure in Patients with Tuberculosis Meningitis Using Physiologically based Pharmacokinetic Modeling;Clinical Pharmacokinetics;2024-03-26

5. Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against Mycobacterium tuberculosis;Frontiers in Medicine;2024-01-10